3.1. Aberrant mRNA Expression of BTLA, CD160, SPN, TIM3, VISTA, TIGIT in CLL and Psoriatic Patients Compared to HVs. This evidence concerns the gene BTLA and B-cell chronic lymphocytic leukemia.